or Try an Advanced Search...

    Astellas Pharma Stocks List

    Symbol Grade Name % Change
    AMGN C Amgen Inc. -0.19
    CYTK D Cytokinetics, Incorporated 1.91
    IRWD D Ironwood Pharmaceuticals, Inc. -2.53
    RPRX F Royalty Pharma plc 0.58
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biotechnology Human Therapeutic Products Neuroscience Pharmaceutical Products Therapeutic Products Amyotrophic Lateral Sclerosis Biopharmaceutical Biopharmaceutical Products Blood Cells Bone Bone Disease Cancer Care Cardiovascular Disease Central Nervous System Disorders Chronic Idiopathic Constipation Clinic Clinical Development Constipation Cytokine Dialysis

    Related ETFs - A few ETFs which own one or more of the above listed Astellas Pharma stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 15.76
    IBBQ C Invesco Nasdaq Biotechnology ETF 10.72
    IBB D iShares Nasdaq Biotechnology Index Fund 9.33
    BIS B ProShares UltraShort Nasdaq Biotechnology 8.38
    BIB D ProShares Ultra Nasdaq Biotechnology 7.9
    View all Astellas Pharma ETFs...
    Compare ETFs
    Compare BBH to IBB Compare IBBQ to BIS Compare IBBQ to IBB

        Astellas Pharma Stocks Recent News

        Date Stock Title
        Apr 24 CYTK Cytokinetics to Announce First Quarter Results on May 8, 2024
        Apr 24 AMGN Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
        Apr 22 AMGN 10 Best Performing Biotech ETFs in 2024
        Apr 20 RPRX Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
        Apr 19 RPRX Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biotechnology Human Therapeutic Products Neuroscience Pharmaceutical Products Therapeutic Products Amyotrophic Lateral Sclerosis Biopharmaceutical Biopharmaceutical Products Blood Cells Bone Bone Disease Cancer Care Cardiovascular Disease Central Nervous System Disorders Chronic Idiopathic Constipation Clinic Clinical Development Constipation Cytokine Dialysis
        Astellas Pharma

        Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha).
        Astellas is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.

        More about Astellas Pharma
        Browse All Tags